DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Pratley RE, Jauffret-Kamel S, Galbreath E et al.
Twelve-week monotherapy with the DPP-4 inhibitor vildagliptin improves glycemic control in subjects with type 2 diabetes.
Horm Metab Res 2006;
38 (06) 423-428
http://www.ncbi.nlm.nih.gov/pubmed/16823726
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.